Efficacy of N-acetylcysteine for Prevention of Postoperative Atrial Fibrillation Following Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Aug 14

PMID 39139444

Authors

Dudy Arman Hanafy

Herick Alvenus Willim

Widya Trianita Suwatri

Alvin Ariyanto Sani

Hengky Khouw

Eunike Ita Susanti

Sugisman

Affiliations

Soon will be listed here.

Abstract

Background: As the prevalence of coronary artery disease rises, the demand for coronary artery bypass grafting (CABG) increases. A common complication after CABG is postoperative atrial fibrillation (POAF), which is linked to adverse clinical outcomes. N-acetylcysteine (NAC), an antioxidant, may mitigate oxidative stress and reduce the incidence of POAF. This meta-analysis aims to investigate the efficacy of NAC in preventing POAF after CABG.

Methods: The meta-analysis was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We systematically searched multiple databases, including PubMed, Cochrane Library, ProQuest, and ScienceDirect, to identify relevant randomized controlled trials (RCTs). The intervention groups received perioperative NAC therapy, while the control groups received a placebo. The outcomes assessed were POAF incidence, all-cause mortality, and hospital length of stay (LOS). Review Manager 5.3 was used to conduct the meta-analysis.

Results: Eleven RCTs involving 648 patients were included. The NAC group comprised 326 patients, while the control group comprised 322 patients. In the pooled analysis, patients in the NAC group had a significantly lower incidence of POAF (odds ratios (OR) = 0.57; 95% confidence intervals (CI) = 0.33 to 0.97; = 0.04) and a shorter hospital LOS (weighted mean differences (WMD) = -0.66; 95% CI = -1.22 to -0.10; = 0.02) compared to the control group. However, there was no significant difference in all-cause mortality.

Conclusions: The perioperative administration of NAC can effectively reduce the incidence of POAF and hospital LOS in CABG patients. However, larger RCTs are needed to confirm these findings.

References

Chelazzi C, Villa G, De Gaudio A . Postoperative atrial fibrillation. ISRN Cardiol. 2012; 2011:203179. PMC: 3262508. DOI: 10.5402/2011/203179. View

Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D . Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4. View

Yesilbursa D, Serdar A, Senturk T, Serdar Z, Sag S, Cordan J . Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction. Heart Vessels. 2006; 21(1):33-7. DOI: 10.1007/s00380-005-0854-4. View

Chau Y, Yoo J, Chuen Yuen H, Bin Waleed K, Chang D, Liu T . The impact of post-operative atrial fibrillation on outcomes in coronary artery bypass graft and combined procedures. J Geriatr Cardiol. 2021; 18(5):319-326. PMC: 8185439. DOI: 10.11909/j.issn.1671-5411.2021.05.005. View

Almashrafi A, Alsabti H, Mukaddirov M, Balan B, Aylin P . Factors associated with prolonged length of stay following cardiac surgery in a major referral hospital in Oman: a retrospective observational study. BMJ Open. 2016; 6(6):e010764. PMC: 4908878. DOI: 10.1136/bmjopen-2015-010764. View

Lewicki L, Siebert J, Rogowski J . Atrial fibrillation following off-pump versus on-pump coronary artery bypass grafting: Incidence and risk factors. Cardiol J. 2016; 23(5):518-523. DOI: 10.5603/CJ.a2016.0066. View

Peker O, Peker T, Erdogan D, Ozaydin M, Kapan S, Sutcu R . Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. J Cardiovasc Surg (Torino). 2008; 49(4):527-31. View

Greenberg J, Lancaster T, Schuessler R, Melby S . Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017; 52(4):665-672. DOI: 10.1093/ejcts/ezx039. View

Raghu G, Berk M, Campochiaro P, Jaeschke H, Marenzi G, Richeldi L . The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Curr Neuropharmacol. 2020; 19(8):1202-1224. PMC: 8719286. DOI: 10.2174/1570159X19666201230144109. View

10.

Eren N, Cakir O, Oruc A, Kaya Z, Erdinc L . Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion. 2004; 18(6):345-50. DOI: 10.1191/0267659103pf696oa. View

11.

Tamis J, Steinberg J . Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery. Clin Cardiol. 2000; 23(3):155-9. PMC: 6654937. DOI: 10.1002/clc.4960230305. View

12.

Yamashita K, Hu N, Ranjan R, Selzman C, Dosdall D . Clinical Risk Factors for Postoperative Atrial Fibrillation among Patients after Cardiac Surgery. Thorac Cardiovasc Surg. 2018; 67(2):107-116. PMC: 6359984. DOI: 10.1055/s-0038-1667065. View

13.

Orhan G, Yapici N, Yuksel M, Sargin M, Senay S, Yalcin A . Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels. 2006; 21(1):42-7. DOI: 10.1007/s00380-005-0873-1. View

14.

Musa A, Dillon J, Taib M, Yunus A, Sanusi A, Nordin M . Incidence and Outcomes of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting of a Randomized Controlled Trial: A Blinded End-of-cycle Analysis. Rev Cardiovasc Med. 2024; 23(4):122. PMC: 11273857. DOI: 10.31083/j.rcm2304122. View

15.

Koramaz I, Pulathan Z, Usta S, Karahan S, Alver A, Yaris E . Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. Ann Thorac Surg. 2006; 81(2):613-8. DOI: 10.1016/j.athoracsur.2005.08.013. View

16.

Alqahtani A . Atrial fibrillation post cardiac surgery trends toward management. Heart Views. 2010; 11(2):57-63. PMC: 3000913. DOI: 10.4103/1995-705X.73212. View

17.

El-Hamamsy I, Stevens L, Carrier M, Pellerin M, Bouchard D, Demers P . Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg. 2007; 133(1):7-12. DOI: 10.1016/j.jtcvs.2006.05.070. View

18.

Wang H, Wang H, Wei Y, Li X, Jhummun V, Ahmed M . Ten-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients with Type 2 Diabetes Mellitus Suffering from Left Main Coronary Disease: A Meta-Analysis. Diabetes Ther. 2021; 12(4):1041-1054. PMC: 7994472. DOI: 10.1007/s13300-021-01025-x. View

19.

Rodrigues A, Evora P, Bassetto S, Alves Jr L, Scorzoni Filho A, Origuela E . Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress. Heart Surg Forum. 2009; 12(1):E44-8. DOI: 10.1532/HSF98.20081134. View

20.

Seo E, Hong J, Lee H, Son Y . Perioperative risk factors for new-onset postoperative atrial fibrillation after coronary artery bypass grafting: a systematic review. BMC Cardiovasc Disord. 2021; 21(1):418. PMC: 8414730. DOI: 10.1186/s12872-021-02224-x. View